FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ADAGRASIB
异名/同义词((2S)-4-(7-(8-CHLORONAPHTHALEN-1-YL)-2-(((2S)-1- METHYLPYRROLIDIN-2-YL)METHOXY)-5,6,7,8- TETRAHYDROPYRIDO(3,4-D)PYRIMIDIN-4-YL)-1-(2-FLUOROPROP2-ENOYL)PIPERAZIN-2-YL)ACETONITRILE
2-PIPERAZINEACETONITRILE, 4-(7-(8-CHLORO-1-NAPHTHALENYL)-5,6,7,8-TETRAHYDRO-2-(((2S)-1-METHYL-2-PYRROLIDINYL)METHOXY)PYRIDO(3,4-D)PYRIMIDIN-4-YL)-1-(2-FLUORO-1-OXO-2-PROPEN-1-YL)-, (2S)-
ADAGRASIB
ADAGRASIB [INN]
ADAGRASIB [USAN]
ADAGRASIB [WHO-DD]
KRAS G12C INHIBITOR MRTX849
KRAZATI
MRTX849
MRTX-849
CAS登记号2326521-71-3
物质唯一标识(Unique Ingredient Identifier)8EOO6HQF8Y
分子式C32H35ClFN7O2
国际化合物标识(International Chemical Identifier,InChI)PEMUGDMSUDYLHU-ZEQRLZLVSA-N
SMILESC(C[C@@H]1N(CCN(C1)c2c3c(nc(n2)OC[C@@H]4CCCN4C)CN(CC3)c5cccc6cccc(c56)Cl)C(C(=C)F)=O)#N
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System